Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2441091
Max Phase: Preclinical
Molecular Formula: C18H15N3O4
Molecular Weight: 337.34
Molecule Type: Small molecule
Associated Items:
ID: ALA2441091
Max Phase: Preclinical
Molecular Formula: C18H15N3O4
Molecular Weight: 337.34
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1cccc(C(=O)Nc2cnc(Oc3ccc(O)cc3)nc2)c1
Standard InChI: InChI=1S/C18H15N3O4/c1-24-16-4-2-3-12(9-16)17(23)21-13-10-19-18(20-11-13)25-15-7-5-14(22)6-8-15/h2-11,22H,1H3,(H,21,23)
Standard InChI Key: DXVCCLPGWMZNIM-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 337.34 | Molecular Weight (Monoisotopic): 337.1063 | AlogP: 3.24 | #Rotatable Bonds: 5 |
Polar Surface Area: 93.57 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 9.48 | CX Basic pKa: 0.09 | CX LogP: 2.86 | CX LogD: 2.86 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.74 | Np Likeness Score: -1.16 |
1. Yamada A, Fujii S, Mori S, Kagechika H.. (2013) Design and Synthesis of 4-(4-Benzoylaminophenoxy)phenol Derivatives As Androgen Receptor Antagonists., 4 (10): [PMID:24900588] [10.1021/ml4001744] |
Source(1):